Review
[The recommendations of the Polish Gynecologic Society regarding the use of darifenacin, selective muscarinic antagonists in the treatment of overactive bladder]
[Article in
Polish]
- PMID: 18200976
Item in Clipboard
Review
[The recommendations of the Polish Gynecologic Society regarding the use of darifenacin, selective muscarinic antagonists in the treatment of overactive bladder]
[Article in
Polish]
Ginekol Pol.
2007 Oct.
No abstract available
Similar articles
-
Solifenacin and darifenacin for overactive bladder.Obstet Gynecol. 2005 Aug;106(2):401-2. doi: 10.1097/01.AOG.0000173816.33966.ed. Obstet Gynecol. 2005. PMID: 16055596 No abstract available.
-
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin.Clin Interv Aging. 2008;3(3):503-9. doi: 10.2147/cia.s3414. Clin Interv Aging. 2008. PMID: 18982920 Free PMC article. Review.
-
Clinical relevance of health-related quality of life outcomes with darifenacin.BJU Int. 2008 Jul;102(2):208-13. doi: 10.1111/j.1464-410X.2008.07523.x. Epub 2008 Jul 1. BJU Int. 2008. PMID: 18325056 Clinical Trial.
-
[Anticholinergics for overactive bladder: does subtype selectivity play a role?].Urologe A. 2006 Jul;45(7):826-9. doi: 10.1007/s00120-006-1075-x. Urologe A. 2006. PMID: 16767455 Review. German.
-
Darifenacin in the treatment of overactive bladder.Drugs Today (Barc). 2005 Jul;41(7):441-52. doi: 10.1358/dot.2005.41.7.891719. Drugs Today (Barc). 2005. PMID: 16193097 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical